The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes patients.

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

But up to half of all dementia cases might be preventable, and scientists have identified over a dozen modifiable risk factors that contribute to dementia risk, including obesity, type 2 diabetes ...

Does Ozempic also hold the secret to a cure for depression and dementia? As Wes Streeting suggests new weight-loss jabs could be given to unemployed people to help them get back into work, doctors ...

The case for Ozempic as a dementia buster is building. Research published this week has found that GLP-1 drugs are associated with a lower risk of dementia in people with type 2 diabetes.

New research suggests that semaglutide, the active ingredient in GLP-1 drugs like Ozempic and Wegovy, might protect against dementia. More than 6 million Americans are diagnosed with dementia each ...

The unexpected ways Ozempic-like drugs might fight dementia. They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

“According to the latest figures released by the NHS, dementia diagnosis is at a record high in England. ... Pharmacist cautions against self-medicating with ozempic for dementia risk reduction.

Blockbuster weight loss jabs relied on by millions of slimmers could slash the risk of developing dementia, two major studies have suggested.. Semaglutide — the powerful ingredient behind Wegovy ...